Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial-Reference-Cited by-同舟云学术

Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial

Published:2017-03-16 Issue:9 Volume:19 Page:1186-1197
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Olivier Arnaud¹²³,Pitt Bertram⁴,Girerd Nicolas¹³⁵⁶,Lamiral Zohra¹³,Machu Jean-Loup¹³,McMurray John J.V.⁷,Swedberg Karl⁸,van Veldhuisen Dirk J.⁹,Collier Timothy J.¹⁰,Pocock Stuart J.¹⁰,Rossignol Patrick¹³⁵⁶,Zannad Faiez¹²³⁵⁶,Pizard Anne¹³⁵⁶

Affiliation:

1. Inserm CIC Plurithématique 1433; UMRS 1116 Inserm CHRU Nancy Vandoeuvre-lès-Nancy France

2. Cardiovascular Department; CHRU Nancy; Vandoeuvre-lès-Nancy France

3. F-CRIN INI-CRCT; France

4. University of Michigan; School of Medicine; Ann Arbor MI USA

5. Université de Lorraine; Nancy France

6. Fédération de Recherche 3209; Vandoeuvre-lès-Nancy France

7. University of Glasgow; Glasgow UK

8. University of Gothenburg; Gothenburg Sweden

9. University Medical Center; Groningen the Netherlands

10. London School of Hygiene and Tropical Medicine; London UK

Funder